Ever Source Wealth Advisors, LLC Celldex Therapeutics, Inc. Transaction History
Ever Source Wealth Advisors, LLC
- $1.95 Billion
- Q2 2025
A detailed history of Ever Source Wealth Advisors, LLC transactions in Celldex Therapeutics, Inc. stock. As of the latest transaction made, Ever Source Wealth Advisors, LLC holds 171 shares of CLDX stock, worth $4,540. This represents 0.0% of its overall portfolio holdings.
Number of Shares
171
Previous 1,438
88.11%
Holding current value
$4,540
Previous $26,000
88.46%
% of portfolio
0.0%
Previous 0.0%
Shares
6 transactions
Others Institutions Holding CLDX
# of Institutions
199Shares Held
68.2MCall Options Held
219KPut Options Held
238K-
Kynam Capital Management, LP Princeton, NJ6.1MShares$162 Million14.83% of portfolio
-
Wellington Management Group LLP Boston, MA5.23MShares$139 Million0.02% of portfolio
-
Black Rock Inc. New York, NY4.69MShares$125 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA3.96MShares$105 Million0.0% of portfolio
-
Price T Rowe Associates Inc Baltimore, MD3.82MShares$101 Million0.01% of portfolio
About Celldex Therapeutics, Inc.
- Ticker CLDX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 46,772,400
- Market Cap $1.24B
- Description
- Celldex Therapeutics, Inc., a biopharmaceutical company, engages in developing therapeutic monoclonal and bispecific antibodies for the treatment of various diseases. Its drug candidates include antibody-based therapeutics to treat patients with inflammatory diseases and various forms of cancer. The company's clinical development programs CDX-01...